Stock Track | Chemed Soars 6.02% in Post-Market Trading on Strong Q1 Earnings Beat and Raised Full-Year Guidance
Stock Track
Apr 24
Chemed's stock surged 6.02% in post-market trading on Thursday, following the release of its first-quarter 2026 financial results that exceeded analyst expectations.
The healthcare and plumbing services company reported adjusted earnings of $5.65 per share, beating the consensus estimate of $5.30. Revenue for the quarter reached $657.5 million, also surpassing expectations of $649.8 million.
Chemed raised its full-year 2026 adjusted EPS guidance to a range of $24.00 to $24.75, up from the previous range of $23.25 to $24.25. The company attributed the strong performance to increased admissions at its VITAS hospice segment, which grew 6.9%, and also raised revenue growth guidance for both its VITAS and American Drain Cleaning segments.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.